Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability
Open Access
- 20 November 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 1268
Abstract
Interfering with tumor metabolism by specifically restricting the availability of extracellular nutrients is a rapidly emerging field of cancer research. A variety of tumor entities depend on the uptake of the amino acid arginine since they have lost the ability to synthesize it endogenously, that is they do not express the rate limiting enzyme for arginine synthesis, argininosuccinate synthase (ASS). Arginine transport through the plasma membrane of mammalian cells is mediated by eight different transporters that belong to two solute carrier (SLC) families. In the present study we found that the proliferation of primary as well as immortalized chronic lymphocytic leukemia (CLL) cells depends on the availability of extracellular arginine and that primary CLL cells do not express ASS and are therefore arginine-auxotrophic. The cationic amino acid transporter-1 (CAT-1) was the only arginine importer expressed in CLL cells. Lentiviral-mediated downregulation of the CAT-1 transporter in HG3 CLL cells significantly reduced arginine uptake, abolished cell proliferation and impaired cell viability. In a murine CLL xenograft model, tumor growth was significantly suppressed upon induced downregulation of CAT-1 in the CLL cells. Our results suggest that inhibition of CAT-1 is a promising new therapeutic approach for CLL.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Cl100/6-1, MU 1547/4-1, SFB1292/1, 06)
This publication has 59 references indexed in Scilit:
- Overexpression of Arginine Transporter CAT-1 Is Associated with Accumulation of L-Arginine and Cell Growth in Human Colorectal Cancer TissuePLOS ONE, 2013
- A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaInvestigational New Drugs, 2012
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemiaNature Cell Biology, 2012
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infectionOncoImmunology, 2012
- SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast CancerJournal of Biological Chemistry, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancerInternational Journal of Cancer, 2010
- Arginase: an emerging key player in the mammalian immune systemBritish Journal of Pharmacology, 2009
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006